In patients undergoing surgery under general anaesthesia diazepam 0.16 mg kg" 1 had no effect on mechanical twitch height of the adductor pollicis muscle of the thumb when the ulnar nerve was stimulated at the wrist. The muscle responses were evoked by single, repeated supramaximal stimuli at 0.2 Hz and "train-of-four" stimulation at 2 Hz for 2 s. Diazepam 0.16 mgkg" 1 had no effect on the depth or recovery of neuromuscular blockade produced by suxamethonium, tubocurarine, pancuronium, fazadinium or alcuronium.
An interaction between diazepam and neuromuscular blocking agents was suggested by Stovner and Endresen (1965) , who believed that premedication with diazepam decreased the requirements for neuromuscular blockade. Although this was not confirmed, either in their later work (Stovner and Endresen, 1966) or by Hunter (1967) , the controversy was re-opened by Feldman and Crawley (1970a, b) who found that diazepam potentiated the neuromuscular blockade produced by gallamine and enhanced the rate of recovery from a neuromuscular blockade by suxamethonium. Studies in animals and man (Dretchen, Ghoneim and Long, 1971 ) and in cats (Webb and Bradshaw, 1973) failed to demonstrate any action of diazepam at the neuromuscular junction in the clinical dose range. In the years following these studies a more sensitive and quantitative measurement of monitoring neuromuscular function by evoking short "trains-of-four" supramaximal stimuli to the ulnar nerve (Ali and Savarese, 1976; Lee and Katz, 1977) has been introduced.
The studies reported in this paper were undertaken to re-examine the controversial interaction of diazepam at the neuromuscular junction in man, using the train-of-four stimulation and single repeated supramaximal stimulation to evoke muscle responses.
diazepam 10 mg orally 1-2 h before operation. Anaesthesia was induced with a dose of thiopentone sufficient to abolish the eyelash reflex. Following the administration of 50-75 mg the trachea was intubated and anaesthesia was maintained subsequently with nitrous oxide 70% in oxygen. Fentanyl was administered in incremental doses of 50-100 y.g i.v. to provide further analgesia. Ventilation was controlled with a tidal volume of 10 ml kg" 1 and a respiratory rate of 14 b.p.m. delivered by a Blease or Manley respirator.
The patient's hand was positioned palm upwards on the Perspex base plate of a force transducer which was designed to limit changes in the position of the thumb while immobilizing the hand by constraining the little finger ( fig. 1 ). The thumb was abducted to obtain a moderate resting tension of the adductor pollicis muscle as described by Ali and Savarese (1976) . The plastic fittings could be interchanged to allow use with either hand. Four electrical strain gauges were mounted on the steel strip protected by a Perspex cover plate. Bending the steel strip resulted in compression of gauges (1) and (2) and extension of strain gauges (3) and (4) (fig. 2) . The four gauges were connected in a Wheatstone bridge circuit in such a way as to eliminate the effects of direct loads, to magnify bending strains by a factor of 4 and to compensate for changes in resistance as a result of temperature variation. A potentiometer was added to correct imbalance from slightly different gauge resistances. The force transducer was connected to a pre-amplifier (3552) and a recorder (Ormed MX212). The apparatus was calibrated by weights ranging from 5 g to 2 kg applied in the direction shown in figure 2. The calibration lines did not differ significantly from linearity; for example, range 100 (r = 0.999) ( fig. 3) .
Following recovery from suxamethonium, the ulnar nerve was stimulated at the wrist using skin (Medelec) or subcutaneous needle electrodes (Grass) connected to a nerve stimulator (Grass S48).
The ulnar nerve was stimulated supramaximally with rectangular pulses at a frequency of 0.2 Hz. Control readings of single twitch and train-of-four fade were made. The latter were trains-of-four supramaximal stimuli applied for 2 s every 10 s. Then the single twitch response was recorded while neuromuscular blocking drugs were injected via an i.v. infusion to the opposite arm. The following neuromuscular blocking agents were investigated: pancuronium, tubocurarine, alcuronium, fazadinium and suxamethonium. Incremental doses of one of these were administered to obtain blockade approx- imately 50% of control. When maximum blockade had been achieved, as observed by both single twitch and train-of-four stimulation, the patient received either diazepam 0.16 mg kg" 1 i.v. or equivalent volumes of saline as a control. Continuous recordings of single twitches interspersed at 3-min intervals with trains-of-four stimuli were made until recovery from the blockade or the requirement, on surgical grounds, for greater relaxation.
The results of the single twitch response were expressed as a percentage of pre-drug control tensions, and the train-of-four stimulation ratio was measured as the height of the fourth to the first twitch expressed as a percentage. Statistical significance was assessed using the Mann-Whitney I/test.
RESULTS
The intravenous administration of diazepam alone had no effect on either the single twitch or the trainof-four stimulation. The doses (mg) of the neuromuscular blocking agents are shown in table I, with the time to maximum neuromuscular blockade measured with train-of-four stimulation ratios or single twitch. This shows that in both control experiments and experiments in which diazepam was given after the development of maximum blockade there was no significant difference between these values and, therefore, the groups were comparable. The greater sensitivity of the train-offour stimulation ratio, expressed as a percentage for The lack of interaction between diazepam and the competitive neuromuscular blocking agents is shown in figure 4 (diazepam was administered following a prior injection of tubocurarine). Compared with control readings, diazepam did not significantly increase the inhibition of twitch height produced by tubocurarine, alcuronium, fazadinium and pancuronium (table II) . Similarly, diazepam had no effect on the marked reduction of the train-of-four stimulation ratio produced by the myoneural blocking drugs (table III) . In table IV the results have been expressed for the rate of recovery as measured by the train-offour ratio and single twitch. Some patients showed no recovery of blockade during the investigation. No significant differences could be detected between control and diazepam-treated patients.
The interaction of diazepam and suxamethonium administered by a single bolus injection or a continuous infusion was studied. Only the single twitch was recorded, as train-of-four stimulation ratio is not applicable to depolarizing blockade. Although quantification was difficult, no interaction between diazepam and suxamethonium was seen ( fig. 5 ).
DISCUSSION
There was no action of diazepam 0.16 mg kg" 1 at the neuromuscular junction and there was no evidence of any interaction between diazepam and the neuromuscular blocking agents tubocurarine, pancuronium, fazadinium, alcuronium or suxamethonium in humans. These results conflict with those of Feldman and Crawley (1970a, b) , who found that diazepam potentiated the duration of the neuromuscular blockade produced by gallamine and enhanced the recovery of blockade from suxamethonium. Since the dose range of diazepam in these studies is comparable, the differences in the findings is probably a result of experimental design. Feldman and Crawley (1970a, b) obtained a control response to the myoneural blocking agent and then injected diazepam before a second dose of the muscle relaxant in the same patient. In our study diazepam was given at the maximum blockade. Control responses and test studies with diazepam were performed in separate patients to avoid artefacts resulting from cumulation of muscle relaxants. This was demonstrated in the experiments in cats by Webb and Bradshaw (1973) , in which a cumulative effect was evident even when more than 2 h had elapsed between injections of gallamine and tubocurarine. Although a neuromuscular junction may have recovered fully from blockade with respect to twitch height and tetanic responses, significant quantities of the muscle relaxants may remain in non-specific binding sites. Thus, a second dose of drug may be bound less and so have a greater action at the neuromuscular junction. In the study by Feldman and Crawley (1970a, b) the results from only four patients who received three different doses of gallamine were reported. Therefore, no statistical analysis of the results was possible and no follow-up study was undertaken. The results of our studies are supported by Dretchen, Ghoneim and Long (1971) , who showed that diazepam in doses as great as 1.2 mg kg"" 1 had no effect on the recovery rate of blockade produced by tubocurarine, gallamine or decamethonium in humans.
Animal experiments have not revealed any action of diazepam in therapeutic doses at the neuromuscular junction. Experiments on the cat anterior tibialis preparation (Hamilton, 1967; Crankshaw and Raper, 1968) showed that diazepam abolished the polysynaptic reflex contractions in a concentration that had no effect on the non-reflexly evoked contractions or on the refractory period of indirectly stimulated muscle.
Similar results were obtained by Southgate and Wilson (1971) . Dretchen, Ghoneim and Long (1971) could demonstrate only blockade of the contractions of cat and dog sciatic nerve-anterior tibialis preparations at high concentrations of diazepam injected i.a. These authors suggested that at these concentrations diazepam had a direct depressant effect on the muscle.
Therefore, as such great concentrations of diazepam are required to produce an effect at the neuromuscular junction, this cannot be the main site of action of the relaxant effect. The probable sites of action remain the supra-spinal structures, such as the reticular activating system, and polysynaptic pathways in the spinal cord (Randall et al., 1961) . A central site of action would explain the effectiveness of diazepam in the treatment of tetanus (Shershin and Katz, 1964; Femi-Pearse, 1966; Hendrickse and Sherman, 1966; Dundee and Haslett, 1970) , for controlling muscle rigidity and spasticity in neurological disorders (Olafson, Mulder and Howard, 1964; Nathan, 1970) or in improving patient acceptability of positive pressure ventilation (BozzaMarrubini and Selenati, 1973) .
